1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes

Journal of Neurochemistry

Volumn 68, Issue 5, 1997, Pages 2216-2219

  Hazell, Alan S ^a,b,c   Itzhak, Yossef ^b   Liu, Huaping ^a,b   Norenberg, Michael D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

1 Methyl 4 phenyl l,2,3,6 tetrahydropyridine; Astrocytes; Glutamate transport; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CARRIER PROTEIN; GLUTAMIC ACID;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; ASTROCYTE; BASAL GANGLION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; NERVE CELL NECROSIS; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA; PARKINSONIA;

EID: 0030911911     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68052216.x     Document Type: Article

References (37)

1. Adams J. D. Jr., Klaidman L. K., and Odunze I. N. (1989) Oxidative effects of MPTP in the midbrain. Res. Commun. Subst. Abuse 10, 169-180.
2. Bender A. S., Woodbury D. M., and White H. S. (1989) β-DL-Methylene-aspartate, an inhibitor of aspartate aminotransferase, potently inhibits L-glutamate uptake into astrocytes. Neurochem. Res. 14, 641-646.
3. Booher J. and Sensenbrenner M. (1972) Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat, and human brain in flask cultures. Neurobiology 2, 97-105.
4. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
5. +. Free Radic. Biol. Med. 13, 581-583.
6. Cohen G., Pasik P., Cohen B., Leist A., Mytilineou C., and Yahr M. D. (1985) Pargyline and deprenyl prevent the toxicity of MPTP in monkeys. Eur. J. Pharmacol. 106, 209-210.
7. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
8. Di Monte D. A., Wu E. Y., Irwin I., DeLanney L. E., and Langston J. W. (1991) Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 258, 594-600.
9. Di Monte D. A., Wu E. Y., DeLanney L. E., Irwin I., and Langston J. W. (1992) Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J. Pharmacol. Exp. Ther. 261, 44-49.
10. Drejer J., Larsson O. M., and Schousboe A. (1982) Characterization of L-glutamate uptake into and release from astrocytes and neurons cultured from different brain regions. Exp. Brain Res. 47, 259-269.
11. Drejer J., Larsson O. M., and Schousboe A. (1983) Characterization of uptake and release processes for D-and L-aspartate in primary cultures of astrocytes and cerebellar granule cells. Neurochem. Res. 8, 231-243.
12. Greenamyre J. T. (1993) Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J. Neural Transm. 91, 255-269.
13. Hazell A. S., Norenberg M. D., and Itzhak Y. (1996) MPTP decreases glutamate uptake in cultured astrocytes. Soc. Neurosci. Abstr. 22, 2130.
14. Heikkila R. E., Manzino L., Cabbat F. S., and Duvoisin R. C. (1984) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311, 467-469.
15. Hexum T. D. and Fried R. (1979) Effects of superoxide radicals on transport (Na + K) adenosine triphosphatase and protection by superoxide dismutase. Neurochem. Res. 4, 73-82.
16. + in the substantia nigra: a key to neurotoxicity. Life Sci. 36, 207-212.
17. Javitch J. A., D'Amato R. J., Strittmatter S. M., and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
18. +) induces oxidative stress in the rodent. Life Sci, 38, 743-749.
19. Langston J. W., Ballard P., Tetrud J. W., and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
20. Levitt P., Pintar J. E., and Breakfield X. O. (1982) Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc. Natl. Acad. Sci. USA 79, 6385-6389.
21. Lowry O. H. and Passonneau J. V. (1972) A Flexible System of Enzymatic Analysis. Academic Press, New York.
22. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
23. Markey S. P., Johannessen J. N., Chiueh C. C., Burns R. S., and Herkenham M. A. (1984) Intraneuronal generation of a pyridinium metabolite may cause drug induced parkinsonism. Nature 311, 464-467.
24. Ohashi M., Amano S., Hazama F., and Handa J. (1993) Hypoxic effects on glutamate uptake in cultured glial cells. Acta Pathol. Jpn. 43, 154-159.
25. Przedborski S., Kostic V., Jackson-Lewis V., Naini A. B., Simonetti S., Fahn S., Carlson E., Epstein C. J., and Cadet J. L. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658-1667.
26. +. Neurosci. Lett. 75, 323-328.
27. Robinson M. B., Djali S., and Buchhalter J. R. (1993) Inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J. Neurochem. 61, 2099-2103.
28. Rosenberg P. A. and Aizenman E. (1989) Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 103, 162-168.
29. Rothstein J. D., Jin L., Dykes-Hoberg M., and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
30. Schousboe A., Drejer J., and Hertz L. (1988) Uptake and release of glutamate and glutamine in neurons and astrocytes in primary cultures, in Glutamine and Glutamate in Mammals, Vol. II (Kvamme E., ed), pp. 21-39. CRC Press, Boca Raton, Florida.
31. Takada M., Li Z. K., and Hattori T. (1990) Astroglial ablation prevents MPTP-induced nigrostriatal neuronal death. Brain Res. 509, 55-61.
32. + neurotoxicity by N-methyl-D-aspartate antagonists. Nature 349, 414-418.
33. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
34. 3H uptake and inhibition by cytochalasin B. J. Cell Biol. 50, 804-817.
35. Weiner H. L., Hashim A., Lajtha A., and Sershen H. (1988) (-)-2-Oxo-4-thiazolidine carboxylic acid attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurotoxicity. Res. Commun. Subst. Abuse 9, 53-60.
36. Wroblewski F. and LaDue J. S. (1955) Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90, 210-213.
37. +, and not bound metabolites, as the operative neurotoxin. Chem. Res. Toxicol. 1, 228-233.